Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers on June 11, 2025. CICC Financial Trading Limited, an exempt principal trader connected with the Offeror, disclosed the closing and unwinding of proprietary positions involving 400,000 shares on June 10, 2025. These dealings were executed for CICC's own account, involving both purchase and sale transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 11, 2025, and is solely responsible for the information contained therein.